Catecholestrogens are postulated to contribute to carcinogenesis by causing DNA damage mediated by reactive oxygen species generated during redox cycling between catechol and quinone estrogens, and by quinone estrogens that can form depurinating adducts. The above hypothesis is based principally on studies of the cancers that develop in renal cortex of hamsters treated with primary estrogens: Hamster kidney can catalyze 2-and 4-hydroxylation of estrogens and support their redox cycling, and the kidneys of estradiol-treated hamsters show evidence of oxidative cellular and DNA damage. Here we used immunocytochemisty to test the postulate that catechol-O-methyltransferase (COMT), the enzyme that can prevent oxidation of catecholestrogens to their quinone derivatives, would be induced in renal cortex of hamsters treated with estradiol or ethinyl estradiol. In kidneys of control hamsters, COMT was localized in cytoplasm of epithelial cells of proximal convoluted tubules, predominantly in the juxtamedullary region where the estrogen-induced cancers arise. After 2-or 4-weeks of treatment with either estrogen, COMT was seen in epithelial cells of proximal convoluted tubules throughout the cortex, and many cells also showed intense nuclear COMT immunoreactivity. Estradiol-induced renal cancers were negative for COMT, but were surrounded by tubules with intense cytoplasmic and nuclear immunostaining. The nucleus-associated COMT was shown by immunoblot analysis to be the soluble form of the enzyme. Using reverse transcription-polymerase chain reaction amplification, hamster kidney COMT was shown to lack the putative nuclear localization signal sequence present in human COMT. A second phase II enzyme, CuZn-superoxide dismutase (CuZnSOD), was shown by immunocytochemistry to remain extranuclear in proximal convoluted tubules of estrogen-treated hamsters, which indicates entry of COMT into the nucleus to be selective. The findings are consistent with the catechol/quinone estrogen hypothesis of estrogen-induced cancer, while the translocation of the enzyme to the nucleus following estrogen treatment suggests a response to a threat to the genome by electrophilic products of catechols.
Introduction
Renal cancers that develop in hamsters treated with estradiol (E 2 *) or estrone for 6-8 months provide a well-characterized model in which estrogens act as complete carcinogens, that is, both as initiators and promoters (1) . The cancers arise in the deep juxtamedullary renal cortex from cells associated with the proximal convoluted tubules: they are estrogen dependent and can metastasize. In this model, estrogen receptor-mediated actions of estrogens as mitogens can be dissociated from their actions as carcinogens since ethinyl estradiol (EE 2 ), a potent mitogenic estrogen, causes only hyperplasia of the proximal convoluted tubules but not cancer (2, 3) . Therefore, the hamster kidney model has been especially useful for gaining insight into how estrogens may contribute to carcinogenesis by mechanisms besides those mediated by the estrogen receptor, in particular, mechanisms that involve reactive oxygen species (ROS). The 2-and 4-hydroxylated catechol metabolites of primary estrogens (2-and 4-OH-CEs) can become a source of potentially genotoxic and cytotoxic ROS (4) . Catecholestrogens (CEs), like xenobiotics with a similar hydroquinone structure, can undergo one electron oxidation to form semiquinone and quinone derivatives and enter into redox cycling. In addition, quinone metabolites of CEs, in particular of 4-OH-CEs, can form depurinating adducts, similar to those resulting from metabolic activation of polycyclic aromatic hydrocarbons (5) . Mechanisms that involve ROS could have special relevance to the genesis of breast cancers, because for mammary ductal epithelial cells, unlike the human endometrium, estrogens that act via the estrogen receptor may not be the proximal mitogens (6) (7) (8) (9) , and because there is mounting evidence of a high level of potentially mutagenic oxidative DNA damage in breast tissue of even normal women (10, 11) .
Several lines of evidence implicate ROS generated from CEs produced in situ, in the initiation of the cancers that develop in the renal cortex of hamsters treated with estrogens. Briefly, microsomes prepared from renal cortex of hamsters express phase I enzymes that can catalyze 4-as well as 2-hydroxylation of E 2 and estrone, and at a rate that is significantly higher than that of microsomes isolated from renal cortex of rats, a species in which estrogens do not cause renal cancers (12, 13) . Changes consistent with oxidative DNA damage and lipid peroxidation have also been identified in kidneys of hamsters treated with E 2 (4). The finding that hamster kidney microsomes catalyze 2-and 4-hydroxylation of EE 2 at a third of the rate of E 2 may partially explain the lack of carcinogenicity of EE 2 for hamster kidney (3).
Catechol-O-methyltransferase (COMT) is considered to be important for protecting cells from genotoxicity and cytotoxicity of catechols, including CEs, by preventing their conversion to quinones. The enzyme has high affinity for both 2-and 4-OH-CEs (14) and has been shown to be expressed in rat kidney in epithelial cells of proximal convoluted tubules (15, 16) . The inactivation of 4-OH-CEs by COMT, however, can be impeded by 2-OH-CEs (17) . This observation led to the postulate that in tissues, such as the hamster kidney, that can catalyze high rates of 4-as well as 2-hydroxylation of estrogens, 4-OH-CEs could remain available for further oxidation and for redox cycling, which makes such tissues vulnerable to the carcinogenic actions of estrogens (4, 18, 19) . The purpose of the present study was to test the postulate that COMT would be induced in renal cortex of hamsters treated with estrogens. This postulate was first tested using immunocytochemistry, because the carcinogenic action of estrogens is known to be restricted to a specific region of the hamster kidney: the proximal convoluted tubules in the juxtamedulary cortex. This was followed by immunoblot analysis of subcellular fractions prepared from the renal cortex of hamsters, in order to confirm the novel finding of a nuclear localization of estrogen-induced COMT. Finally, in order to demonstrate specificity of up-regulation of nuclear COMT, immunocytochemistry was carried out for CuZn superoxide dismutase (CuZnSOD), a phase II enzyme also expressed in hamster kidney in cytoplasm of epithelial cells of proximal convoluted tubules.
Materials and methods

Animals and tissue preparation
Male Syrian hamsters (Charles River) were purchased at 30-40 days of age and implanted with pellets of cholesterol mixed with E 2 or EE 2 after a minimum of 1 week of quarantine and habituation. Controls were sham operated. The three experimental groups were housed in separate isolation cubicles. After 2 or 4 weeks of estrogen treatment, the hamsters were killed by decapitation (four hamsters/experimental group). Kidneys were excised, fixed in 10% neutral buffered formalin and embedded in paraffin. Sections (6 µm) cut from these tissue blocks were deparaffinized and used for immunocytochemistry. Sections were also obtained from renal tumor obtained from hamsters that had been treated with E 2 for 8 months.
In pilot experiments we compared the anatomical distribution and subcellular localization of immunoreactive COMT in cryostat sections cut from flashfrozen tissue, with those in sections obtained from paraffin embedded tissue. Tissue was obtained from both control and estrogen-treated hamsters. One kidney from each hamster was flash-frozen, stored at -70°C and cut on a cryostat, while the other kidney was fixed in 10% neutral formalin and embedded in paraffin. COMT was identified using a peroxidase/antiperoxidase detection system, which avoided the high background seen in cryostat sections of kidneys when using biotin/avidin amplification. These experiments established that at the anatomical level, the method of tissue preparation did not affect the localization of COMT: Immunoreactive COMT was localized in the proximal convoluted tubules, and the immunopositive tubules had a similar distribution in the renal cortex, irrespective of the method of tissue preparation. However, nuclear COMT was seen only in sections from paraffin embedded tissue. Subsequent definitive experiments were then carried out using paraffin-embedded tissue, which permitted the use of biotin/avidin amplification and revealed nuclear localization of COMT.
Immunocytochemistry
COMT protein was identified using a rabbit polyclonal antibody developed against the purified protein and at a dilution of 1:2500. This antibody has been extensively characterized and used for immunolocalization of COMT in diverse tissues and in a variety of species (15, 20, 21) . The signal from biotinylated secondary antibody was amplified using Vectastain ABC reagent (Vector, Burlingame, CA) with alkaline phosphatase as the reporter, 5-bromo-4-chloro-3-indolyl phosphate (Boehringer Mannheim, Indianapolis, IN) as substrate and 4-nitroblue tetrazolium (Sigma, St Louis, MO) as the chromogen. Endogenous alkaline phosphatase was inhibited by pre-incubation of sections with 0.2 N HCl for 5 min. To test the specificity of induction of nuclear COMT by estrogen, immunocytochemistry was carried out for CuZnSOD, a second phase II enzyme, using a polyclonal antibody at a 1:500 dilution. This antibody has been used previously to characterize the localization of CuZnSOD proximally in hamster kidney (22) .
Immunoblot analyses of COMT in cell nuclei and subcellular fractions
The renal cortex was microdissected from three groups of hamsters: controls and hamsters treated with E 2 or EE 2 for 2 weeks. Tissue from three animals in each treatment group was pooled, nuclei were purified by sedimentation through a 2.1-M sucrose-buffer cushion, and cytosolic and microsomal 1308 fractions were prepared by differential centrifugation as described previously (23) . Cytosolic, microsomal and purified nuclear fractions were sonicated briefly, proteins were separated by SDS-PAGE and transferred to Immobilon membranes for immunodetection as described previously (24) . The primary, polyclonal rabbit anti-COMT antibody, and the secondary donkey anti-rabbit antibody coupled to horseradish peroxidase (Amersham, Arlington Heights, IL) were both used at a 1:2500 dilution. ECL reagents were used for detection according to the manufacturer's direction (Amersham, Arlington Heights, IL). Membranes were exposed to X-ray film for periods that ranged typically from several seconds to minutes. Sequencing of region in hamster COMT that encompasses the putative nuclear localization signal in human COMT Entry of proteins into the nucleus via nuclear pores is often directed by a nuclear localization signal (NLS) comprised of clusters of arginine and lysine (24) (25) (26) . Sequences for COMT from human, rat and pig are known, and the three show a high degree of conservation (27) . A classical putative NLS, however, is only found in COMT of humans. To determine whether hamster COMT also possesses an NLS, the region encompassing the putative NLS in human COMT (VGDKKGK 98 IV) was amplified using reverse transcription/ polymerase chain reaction (RT-PCR). The primers used in the reactions correspond to conserved regions in the three species for which the sequence of COMT is known. The 5Ј primer was 5Ј-GACACCTACTGCRMRCA-GAAGG-3Ј and the reverse complementary 3Ј primer was 5Ј-GACCATGTCY-AGTGTGTCCAC. These primers correspond to amino acids 30-36 and 132-138 of human COMT, respectively (27) (R ϭ A or G, M ϭ C or A, K ϭ G or T and Y ϭ T or C). RT-PCR was performed as described previously (24) . The PCR product was cloned into pCRII vector and sequenced in both directions.
Results
Immunocytochemistry
Immunoreactive COMT was localized in epithelial cells of proximal convoluted tubules of both control (untreated) and estrogen-treated hamsters, in particular in vasa recti. In control animals, the reaction product was most prominent in proximal convoluted tubules in the juxtamedullary cortex. Immunostaining was largely cytoplasmic, with only occasional cell nuclei showing the reaction product (Figure 1a-c) . Estrogentreatment affected both the intensity and distribution of COMT immunoreactivity, as well as its subcellular distribution. Treatment with either E 2 or EE 2 caused a marked increase in intensity of immunostaining in epithelial cells of proximal convoluted tubules, in particular those in the juxtamedullary cortex, as well as the appearance of immunoreactive COMT in proximal convoluted tubules throughout the more superficial renal cortex (Figure 1d) . A striking and unexpected effect of estrogen-treatment was the appearance of prominent staining of nuclei of epithelial cells in many proximal convoluted tubules (Figure 1e and f). Regions with many COMT-positive nuclei were interspersed with regions in which the reaction product was restricted to the cytoplasm. The increase in the extent and intensity of COMT immunostaining, and the appearance of nuclear COMT, was seen in kidneys of all estrogen-treated hamsters (n ϭ 16). There were no obvious differences between hamsters treated for 2 or 4 weeks, or between those treated with E 2 or EE 2 , with respect to number of proximal convoluted tubules that showed immunostaining, their anatomical distribution, or the intensity of staining. Estrogen-induced tumors were devoid of immunoreactive COMT, but were surrounded by tubules lined by epithelial cells that showed intense nuclear as well as cytoplasmic COMT (Figure 2a and b) .
Immunostaining for CuZnSOD, like that for COMT, was seen in epithelial cells of proximal convoluted tubules. Immunoreactivity for CuZnSOD, however, was prominent only in the cytoplasm in kidneys of both control and estrogen-treated hamsters. The difference in cellular localization of these In kidney of a hamster treated with estradiol, immunostaining for COMT is more intense and is seen in proximal convoluted tubules throughout the cortex (cortex, left; medulla, right) (magnification ϫ125). (e) At higher magnification, the reaction product is seen in both cytoplasm and nuclei (magnification ϫ500). (f) Prominent nuclear staining is also present in more superficial pars convoluta, as seen in this periglomerular portion of the proximal tubule (G, glomerulus) (magnification ϫ500). two phase II enzymes, and the selective nature of nuclear localization of COMT, is illustrated in Figure 3 . Adjacent to the section showing intense nuclear COMT staining, taken from kidneys of hamsters treated for 2 weeks with E 2 , there are sections with intense immunostaining for CuZnSOD only around, but not within, nuclei of epithelial cells of proximal convoluted tubules.
Immunoblot analyses
Nuclear, cytosolic and crude microsomal fractions enriched with endoplasmic reticulum (ER) were prepared from renal 1309 Fig. 3 . Immunoreactive COMT (left) and CuZn-superoxide dismutase (right) in proximal convoluted tubules from the same region in adjacent tissuesections from kidney of a hamster treated for 2 weeks with estradiol (magnification ϫ500). Intense immunostaining for COMT is seen within many nuclei in contrast to the perinuclear immunostaining for CuZnSOD. Arrows point to some of the cells with distinct nuclear immunostaining for COMT (left) and perinuclear immunostaining for CuZnSOD (right).
Fig. 4.
Immunoblot analyses of COMT in nuclear (Nuc), cytosolic (Cyto) and crude microsomal (ER) subcellular fractions prepared by differential centrifugation from renal cortex of hamsters treated for 2 weeks with estradiol (E 2 ) or ethinylestradiol (EE 2 ), and of control animals (75 µg protein/lane), taken from pooled samples from three animals from each treatment group): Lanes 1, 4 and 7, control hamsters; lanes 2, 5 and 8, E 2 treated hamsters; lanes 3, 6 and 9, EE 2 treated hamsters. Upper band corresponds to M-COMT (M r µ 29 000) and the lower band to S-COMT (M r µ 26 000). Intense immunostaining corresponding to S-COMT is seen in cytosolic and crude microsomal (ER) fractions of all experimental groups. Strong immunoreactivity corresponding to S-COMT is seen in nuclear fraction from the estrogen-treated animals, but only a faint band is seen in nuclear fractions of controls In all, except the nuclear fraction S-COMT, is seen as a distinct doublet, a phenomenon not previously noted. Intense M-COMT immunoreactivity is seen in the nuclear and microsomal fraction of all three experimental groups. cortex of control, E 2 -and EE 2 -treated hamsters and examined for immunoreactive COMT. As previously reported, two forms of COMT were observed; a larger (M r µ 29 000) and a smaller form (M r µ 26 000), which corresponded to the membrane bound (M-COMT) and soluble (S-COMT) forms of COMT, respectively (Figure 4 ). In the cytosolic fraction, S-COMT was the only significant form present (Figure 4, lanes 1-3,  lower bands) . In the nuclear fraction from controls there was only a faint band corresponding to S-COMT (Figure 4 , lane 4, lower band), whereas in nuclear fractions from E 2 -or EE 2 -treated hamsters there was a clear band corresponding to S-COMT (Figure 4, lanes 5 and 6, lower band) . In contrast, M-COMT that was also contained in the nuclear fraction, appeared to be unaffected by treatment with either estrogen (Figure 4, lanes 4-6, upper band) . The crude microsomal fraction also contained both S-and M-COMT, and there was no obvious change in either form after treatment with E 2 or EE 2 ( Figure 4, lanes 7-9) . It should be noted that endoplasmic membrane-enriched crude microsomal fractions, prepared from kidneys by standard methodology, contain a higher proportion of microsomes derived from plasma membrane, as well as mitochondria, than microsomal fractions prepared by the same method from livers (28) . This difference is caused by, presumably, the differences in relative amounts of endoplasmic GTG ATT CGT GAG TAT CGT CCC TCG CTG GTG CTG GAG CTA GGA GCT TAC TGT GGC TAC TCA GCC GTG CGG ATA  GTG ATT CAG GAG CAC CAG CCC TCC GTG CTG CTG GAG CTG GGG GCC TAC TGT GGC TAC TCA GCT GTG CGC ATG  V  I 
Hamster sequence was obtained by RT-PCR using primers for conserved regions of COMT in the three species with known sequences, and which in the human sequence encompasses a putative nuclear localization signal (27) . Differences in predicted amino acid (AA) sequences of hamster COMT, as compared with that of human COMT, are marked by asterisk. Underlined, predicted putative nuclear localization signal AA of human COMT (KKGK), and a second sequence (KKKY) present also in rat COMT, have been suggested to constitute a presumptive NLS (31) . This sequence is also not represented in hamster COMT.
reticulum, plasma membrane and mitochondria in the two tissues. Because the primary objective of these experiments was to confirm an increase in the amount of nucleus-associated COMT identified cytochemically, we did not carry out the additional steps needed to obtain a better separation of microsomes formed from plasma membranes and endoplasmic reticulum, and to reduce the amount of cytosol incorporated in the crude microsomal fraction (29) .
Sequencing of the region in hamster that encompasses a putative NLS in human COMT sequence
RT-PCR obtained using primers flanking the putative NLS in human and rat COMT yielded an amplified product of the anticipated length (327 nt) that was 73% identical at the deduced amino acid level and 78% identical at the nucleotide level with human COMT (Table I ). There was no NLS evident in the hamster COMT within the region sequenced. The predicted amino acid sequence of hamster COMT corresponding to the NLS in the human COMT was VGDAKGQ 98 IM (Table I) .
Discussion
Localization of immunoreactive COMT in kidney of control hamsters identified in this study is similar to that reported for rat kidney (16) . In both species, COMT is seen in the cytoplasm of epithelial cells of proximal convoluted tubules, in particular, in tubules of the juxtamedullary region. The finding of an increase in the intensity of COMT immunoreactivity in proximal convoluted tubules following estrogen treatment, and in the number of such tubules expressing the protein, is consistent with the notion that estrogens cause a localized increase in the amount of catechols that require inactivation within or in the vicinity of proximal tubules. A novel finding is the nuclear localization of COMT in epithelial cells of proximal convoluted 1310 tubules of estrogen-treated hamsters. The absence of any significant nuclear immunostaining for CuZnSOD in epithelial cells that show intense nuclear COMT indicates that upregulation of nuclear COMT is selective. Two additional phase II enzymes, MnSOD and class I alcohol dehydrogenase, were also found by ICC to remain extranuclear in kidneys of estrogen-treated hamsters (unpublished observation). Together, the findings suggest that the up-regulation of nuclear COMT represents a response to a threat to the genome by catechols that can be blocked by their O-methylation. The proposition that CEs generated in situ may make a significant contribution to a potentially damaging catechol load is supported by the demonstrated ability of renal cortex to convert primary estrogens to their 2-and 4-hydroxylated catechol metabolites in vitro, and the presence in cell nuclei of enzymes that can support oxidation and reduction of steroid and stilbene estrogens (30) . The contribution that dopamine generated within epithelial cells lining the proximal tubules may make to local catechol load is discussed below. Nuclear localization of immunoreactive COMT is not unique to kidneys of estrogen-treated hamsters, since it is also seen in human breast cancer tissue (unpublished data). Nuclear localization of S-COMT was also demonstrated in a recent study of the subcellular distribution of recombinant S-COMT and M-COMT, expressed in mammalian cell lines (31) .
CEs are potent competitive inhibitors of the inactivation of catecholamines by COMT (14) . Hence, CEs generated in kidneys of estrogen-treated hamsters could not only pose a threat to the genome, but perturb local catecholamine homeostasis. Dopamine synthesized in proximal convoluted tubules serves to regulate naturesis (32) , and COMT expressed selectively in proximal convoluted tubules is likely to participate in the regulation of electrolyte homeostasis by modulating local dopamine levels. Induction by estrogens of COMT in proximal convoluted tubules of hamsters could, therefore, serve not only to prevent formation of quinone estrogens and redox cycling of CEs, but to prevent excessive loss of sodium because of competition between dopamine and CEs for COMT. Expression of COMT preferentially in the juxtamedullary region of the kidneys in control animals could also be related to the role of COMT in electrolyte homeostasis, since nephrons that arise in the superficial and deep portions of the kidney cortex are known to differ, not only anatomically, but functionally (33) . Together, these findings underscore the potential importance for carcinogenesis of interactions between CEs and other catechols, including catecholamines, by virtue of their dependence on the same phase II enzyme for inactivation.
Contrary to our expectations, there were no differences between the effects of E 2 or EE 2 , despite differences in their carcinogenicity for hamster kidney, and in the rates of their conversion by hamster kidney microsomes to their respective catechol metabolites (3) . One explanation could be that even the lower catechol load caused by aromatic hydroxylation of EE 2 causes maximal induction of COMT. Testing this notion will require establishing a dose-response relationship between CEs and COMT expression, using methodology that can take into account the marked regional differences in COMT expression in hamster kidney cortex. Factors besides the lower rate of conversion of EE 2 to CEs could also contribute to its lack of carcinogenicity for hamster kidney. For example, EE 2 can bind to receptors for progesterone and glucocorticoids, and may therefore act as a partial agonist of these two steroids that can counter carcinogenicity of E 2 for hamster kidney (3).
There have been only a few studies of the regulation of COMT in any tissue. In rat kidney COMT is known to be regulated developmentally (16) , and in rat uterus progesterone has been shown to induce COMT (21) . Expression of COMT in normal breast parenchyma and in neoplastic human and rodent mammary gland has also been described (20, 34) . Whether COMT in breast tissue is regulated hormonally remains to be determined.
As demonstrated by immunoblot analysis, it is the soluble form of COMT that was translocated into the nucleus by the estrogen treatment. This is of interest because of the marked differences in the kinetic characteristic of soluble and membrane-bound forms of COMT with respect to both CEs and catecholamines (35, 36) : S-COMT has an affinity for 2-and 4-OH-CEs an order of magnitude higher than for catecholamines (14, 37) . The affinity of M-COMT for catecholamines is one order of magnitude higher than that of S-COMT (35) , although the two forms have a similar high affinity for 2-OH-CEs (35) . The kinetic characteristics of S-and M-COMT with respect to 4-OH-CEs, the form of CEs postulated to play a special role in carcinogenesis, remain to be determined.
Nuclear localization of a phase II protective enzyme after treatment with a carcinogen, although novel for COMT, has been previously reported for other phase II enzymes, including enzymes that lack an NLS, e.g. glutathione S-transferases (38) (39) (40) . The mechanism(s) underlying this phenomenon remains to be determined. As demonstrated here in the case of COMT, an NLS is not required for the enzyme to be translocated into the nucleus. Similarly, Ulmanen and co-workers demonstrated that eliminating an NLS from human COMT by site-directed mutagenesis did not prevent entry of recombinant S-COMT into nuclei of transfected mammalian cells (31) . Paradigms, besides those associated with NLS, have been identified that could regulate entry of proteins into the nucleus. For example, many receptors translocate to the nucleus upon binding to their ligand, and 1311 there are well-known examples of changes in distribution of proteins between cytoplasm and nucleus in relation to the cell cycle (25, 26, 41) .
In summary, the induction of COMT in hamster kidney by estrogens is consistent with the CE/quinone estrogen hypothesis. The findings also raise a number of questions. These include, determining the mechanisms that regulates the expression of COMT, the interactions between catecholamines and potentially carcinogenic exogenous and endogenous catechols, the basis for the differences in carcinogenicity of E 2 and EE 2 for hamster kidney, as well as the more general question of the mechanisms that cause selective altered compartmentation of phase II protective enzymes between nucleus and cytoplasm and of its biological significance.
